BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37742799)

  • 1. AT
    Villela DC; Namsolleck P; Reichetzeder C; Moll GN
    Peptides; 2023 Dec; 170():171106. PubMed ID: 37742799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type 2 receptor ligand PD123319 attenuates hyperoxia-induced lung and heart injury at a low dose in newborn rats.
    Wagenaar GT; Sengers RM; Laghmani el H; Chen X; Lindeboom MP; Roks AJ; Folkerts G; Walther FJ
    Am J Physiol Lung Cell Mol Physiol; 2014 Aug; 307(3):L261-72. PubMed ID: 24951776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis.
    Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corcetto F; Corno C; Maneschi E; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
    J Steroid Biochem Mol Biol; 2017 Apr; 168():26-37. PubMed ID: 28115235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury.
    Cortijo J; Iranzo A; Milara X; Mata M; Cerdá-Nicolás M; Ruiz-Saurí A; Tenor H; Hatzelmann A; Morcillo EJ
    Br J Pharmacol; 2009 Feb; 156(3):534-44. PubMed ID: 19154443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LP2, the first lanthipeptide GPCR agonist in a human pharmacokinetics and safety study.
    Namsolleck P; Richardson A; Moll GN; Mescheder A
    Peptides; 2021 Feb; 136():170468. PubMed ID: 33253776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycina.
    Tian XL; Yao W; Guo ZJ; Gu L; Zhu YJ
    Chin Med Sci J; 2006 Sep; 21(3):145-51. PubMed ID: 17086734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant replacement therapy reduces acute lung injury and collapse induration-related lung remodeling in the bleomycin model.
    Steffen L; Ruppert C; Hoymann HG; Funke M; Ebener S; Kloth C; Mühlfeld C; Ochs M; Knudsen L; Lopez-Rodriguez E
    Am J Physiol Lung Cell Mol Physiol; 2017 Aug; 313(2):L313-L327. PubMed ID: 28450283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LP2, a stable lanthipeptide derived from cAng-(1-7), exerts myeloprotective action in mice.
    Namsolleck P; Rodgers KE; Franklin R; Moll GN
    Eur J Haematol; 2023 May; 110(5):534-539. PubMed ID: 36656652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of bleomycin-induced pulmonary hypertension and pulmonary fibrosis by the endothelin receptor antagonist Bosentan.
    Schroll S; Arzt M; Sebah D; Nüchterlein M; Blumberg F; Pfeifer M
    Respir Physiol Neurobiol; 2010 Jan; 170(1):32-6. PubMed ID: 19931426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury.
    Rathinasabapathy A; Horowitz A; Horton K; Kumar A; Gladson S; Unger T; Martinez D; Bedse G; West J; Raizada MK; Steckelings UM; Sumners C; Katovich MJ; Shenoy V
    Front Physiol; 2018; 9():180. PubMed ID: 29636695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung vagal afferent activity in rats with bleomycin-induced lung fibrosis.
    Schelegle ES; Walby WF; Mansoor JK; Chen AT
    Respir Physiol; 2001 May; 126(1):9-27. PubMed ID: 11311307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-α.
    Sewing AC; Kantores C; Ivanovska J; Lee AH; Masood A; Jain A; McNamara PJ; Tanswell AK; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(1):L75-87. PubMed ID: 22582114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor.
    Wang R; Ibarra-Sunga O; Verlinski L; Pick R; Uhal BD
    Am J Physiol Lung Cell Mol Physiol; 2000 Jul; 279(1):L143-51. PubMed ID: 10893213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifibrosis effects of total glucosides of Danggui-Buxue-Tang in a rat model of bleomycin-induced pulmonary fibrosis.
    Gao J; Huang Y; Li P; Xu D; Li J; Liu Y; Huang Z; Wu Q; Shao X
    J Ethnopharmacol; 2011 Jun; 136(1):21-6. PubMed ID: 21421041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice.
    Namsolleck P; de Vries L; Moll GN
    Peptides; 2023 Feb; 160():170920. PubMed ID: 36493954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury.
    Wagenaar GT; Laghmani el H; Fidder M; Sengers RM; de Visser YP; de Vries L; Rink R; Roks AJ; Folkerts G; Walther FJ
    Am J Physiol Lung Cell Mol Physiol; 2013 Sep; 305(5):L341-51. PubMed ID: 23812633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung volume quantified by MRI reflects extracellular-matrix deposition and altered pulmonary function in bleomycin models of fibrosis: effects of SOM230.
    Egger C; Gérard C; Vidotto N; Accart N; Cannet C; Dunbar A; Tigani B; Piaia A; Jarai G; Jarman E; Schmid HA; Beckmann N
    Am J Physiol Lung Cell Mol Physiol; 2014 Jun; 306(12):L1064-77. PubMed ID: 24727584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis.
    Howell DC; Goldsack NR; Marshall RP; McAnulty RJ; Starke R; Purdy G; Laurent GJ; Chambers RC
    Am J Pathol; 2001 Oct; 159(4):1383-95. PubMed ID: 11583966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats.
    Corboz MR; Zhang J; LaSala D; DiPetrillo K; Li Z; Malinin V; Brower J; Kuehl PJ; Barrett TE; Perkins WR; Chapman RW
    Pulm Pharmacol Ther; 2018 Apr; 49():95-103. PubMed ID: 29408757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intramuscular injection of hepatocyte growth factor plasmid DNA with electroporation on bleomycin-induced lung fibrosis in rats.
    Long X; Xiong SD; Xiong WN; Xu YJ
    Chin Med J (Engl); 2007 Aug; 120(16):1432-7. PubMed ID: 17825173
    [TBL] [